IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model

BACKGROUND: Prostate cancer is one of the most common adult malignancies in men, and nearly all patients with metastatic prostate cancer can develop and receive resistance to primary androgen deprivation therapy (ADT), a state known as metastatic castration-resistant prostate cancer (mCRPC). Recent...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Transl Med
Asıl Yazarlar: Wang, Dawei, Shao, Yuan, Zhang, Xiang, Lu, Guoliang, Liu, Boke
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961333/
https://ncbi.nlm.nih.gov/pubmed/31937346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-02206-w
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller